2017-24121. Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at https://www.reginfo.gov/​public/​do/​PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.

    Table 1—List of Information Collections Approved by OMB

    Title of collectionOMB control No.Date approval expires
    Submission of Petitions: Food Additive, Color Additive (Including Labeling), Submission to Information to a Master File in Support of Petitions; and Electronic Submission Using FDA 30530910-00169/30/2020
    Voluntary Cosmetic Registration Program0910-00279/30/2020
    Radioactive Drug Research Committees0910-00539/30/2020
    FDA Safety Communication Readership Survey0910-03419/30/2020
    Medical Devices; Reports for Corrections and Removals0910-03599/30/2020
    Generic FDA Rapid Response Surveys0910-05009/30/2020
    Guidance for Industry: Pharmacogenomic Data Submissions0910-05579/30/2020
    Cosmetic Labeling Regulations0910-05999/30/2020
    Annual Reporting for Custom Device Exemption0910-07679/30/2020
    GFI: E6(R2) Good Clinical Practice; International Council for Harmonisation0910-08439/30/2020
    DeNovo Classification Process (Evaluation of Automatic Class II Designation)0910-08449/30/2020
    Start Signature

    Dated: November 1, 2017.

    Anna K. Abram,

    Deputy Commissioner for Policy, Planning, Legislation, and Analysis.

    End Signature End Supplemental Information

    [FR Doc. 2017-24121 Filed 11-3-17; 8:45 am]

    BILLING CODE 4164-01-PStart Printed Page 51425

Document Information

Published:
11/06/2017
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2017-24121
Pages:
51424-51425 (2 pages)
Docket Numbers:
Docket Nos. FDA-2010-N-0258, FDA-2010-N-0623, FDA-2007-N-0383, FDA-2009-N-0360, FDA-2016-N-4620, FDA-2013-N-1496, FDA-2007-N-0220, FDA-2017-N-1848, FDA-2017-N-1066, FDA-2015-D-3327, FDA-2011-D-0689
PDF File:
2017-24121.pdf